retatrutide and heart Data: What Surprised Cardiologists Inotropic effects of retatrutide in

153 MeierJJKemmeriesGHolstJJNauckMA

Our team will assess your unique needs to recommend the most effective weight loss medication for you

Heres what early studies have shown: Pancreatitis: Reported in about 0.4% Gallbladder problems: Seen in about 1.1% , with no cases in the placebo group Heart rhythm changes: Reported more often with retatrutide ( about 6% vs 3% with placebo ) Liver enzyme increases: Rare (around 1% ), with overall liver health markers staying stable While these serious side effects were uncommon, theyre still important to keep in mind

The goal of GLP-1 therapy should be to lose fat and keep muscle not just to lose weight

through approximately 2033